2025 annual financial data
Akebia Therapeutics 2025 Operating margin
Direct answer
Operating margin was 9.95%.
Operating income was 23,499,000 USD and net income was -5,345,000 USD.
Operating cash flow was 67,992,000 USD.
Get free Akebia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 236,196,000 USD
- Operating income
- 23,499,000 USD
- Net income
- -5,345,000 USD
- Operating cash flow
- 67,992,000 USD